85 related articles for article (PubMed ID: 4363075)
1. Thyroid hormone action: demonstration of putative nuclear receptors in human lymphocytes.
Tsai JS; Samuels HH
J Clin Endocrinol Metab; 1974 May; 38(5):919-22. PubMed ID: 4363075
[No Abstract] [Full Text] [Related]
2. Thyroid hormone action: in vitro demonstration of putative receptors in isolated nuclei and soluble nuclear extracts.
Samuels HH; Tsai JS; Casanova J
Science; 1974 Jun; 184(4142):1188-91. PubMed ID: 4364362
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells.
Samuels HH; Tsai JS; Casanova J; Stanley F
J Clin Invest; 1974 Oct; 54(4):853-65. PubMed ID: 4372251
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an active step in thyroid hormone transport to nuclei: drug inhibition of L-125I-triiodothyronine binding to nuclear receptors in rat pituitary tumor cells.
Halpern J; Hinkle PM
Endocrinology; 1982 Mar; 110(3):1070-2. PubMed ID: 6276153
[TBL] [Abstract][Full Text] [Related]
5. In vitro 3,5,3'-triiodothyronine binding to rat cerebrocortical neuronal and glial nuclei suggests the presence of binding sites unavailable in vivo.
Kolodny JM; Larsen PR; Silva JE
Endocrinology; 1985 May; 116(5):2019-28. PubMed ID: 2985367
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action.
Bernal J; Refetoff S; DeGroot LJ
J Clin Endocrinol Metab; 1978 Dec; 47(6):1266-72. PubMed ID: 233694
[TBL] [Abstract][Full Text] [Related]
7. Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only.
Lim VS; Passo C; Murata Y; Ferrari E; Nakamura H; Refetoff S
Endocrinology; 1984 Jan; 114(1):280-6. PubMed ID: 6317348
[TBL] [Abstract][Full Text] [Related]
8. Triiodothyronine receptors in lymphocytes of newborn and adult rats.
Csaba G; Sudár F; Dobozy O
Horm Metab Res; 1977 Nov; 9(6):499-501. PubMed ID: 201551
[TBL] [Abstract][Full Text] [Related]
9. Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary.
Cheron RG; Kaplan MM; Larsen PR
J Clin Invest; 1979 Nov; 64(5):1402-14. PubMed ID: 227934
[TBL] [Abstract][Full Text] [Related]
10. In vitro binding of L-triiodothyronine to receptors in rat liver nuclei. Kinectics of binding, extraction properties, and lack of requirement for cytosol proteins.
Surks MI; Koerner DH; Oppenheimer JH
J Clin Invest; 1975 Jan; 55(1):50-60. PubMed ID: 162784
[TBL] [Abstract][Full Text] [Related]
11. Characterization of thyroid hormone stimulation of uridine uptake by rat pituitary tumor cells.
Halpern J; Hinkle PM
Endocrinology; 1984 Jul; 115(1):95-101. PubMed ID: 6329664
[TBL] [Abstract][Full Text] [Related]
12. Organization of the thyroid hormone receptor in chromatin.
Samuels HH; Perlman AJ; Raaka BM; Stanley F
Recent Prog Horm Res; 1982; 38():557-99. PubMed ID: 6289395
[No Abstract] [Full Text] [Related]
13. Photoaffinity labelling of the rat liver nuclear thyroid hormone receptor with [125I]triiodothyronine.
David-Inouye Y; Somack R; Nordeen SK; Apriletti JW; Baxter JD; Eberhardt NL
Endocrinology; 1982 Nov; 111(5):1758-60. PubMed ID: 6290199
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor decreases thyroid hormone receptors and attenuates thyroid hormone responses in GH4C1 cells.
Kaji H; Hinkle PM
Endocrinology; 1987 Feb; 120(2):537-43. PubMed ID: 3492366
[TBL] [Abstract][Full Text] [Related]
15. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.
Silva JE; Larsen PR
J Clin Invest; 1978 May; 61(5):1247-59. PubMed ID: 207733
[TBL] [Abstract][Full Text] [Related]
16. The rate of appearance of thyroid hormone nuclear receptor is increased during deoxyribose nucleic acid synthesis in GC cells: analysis of thymidine-treated GC cells using dense amino acid labeling.
Shapiro LE; Patel KR; Surks MI
Endocrinology; 1986 Nov; 119(5):2076-81. PubMed ID: 3769862
[TBL] [Abstract][Full Text] [Related]
17. Increase in nuclear thyroid and glucocorticoid receptors and growth hormone production during the deoxyribonucleic acid synthesis phase of the cell growth cycle.
Surks MI; Kumara-Siri MH
Endocrinology; 1984 Mar; 114(3):873-9. PubMed ID: 6321144
[TBL] [Abstract][Full Text] [Related]
18. Nuclear 3,5,3'-triiodothyronine receptor concentration increases during deoxyribonucleic acid synthesis in partially synchronized GC cell cultures.
DeFesi CR; Fels EC; Surks MI
Endocrinology; 1982 Oct; 111(4):1156-65. PubMed ID: 6288349
[No Abstract] [Full Text] [Related]
19. [Features of triiodothyronine reception in incorporation of radioactive iodine].
Nikolaeva LA; Danilova LI; Kholodova EA
Probl Endokrinol (Mosk); 1994; 40(5):47-8. PubMed ID: 7899444
[TBL] [Abstract][Full Text] [Related]
20. In vitro demonstration of specific triiodothyronine binding sites in rat liver nuclei.
Koerner D; Surks MI; Oppenheimer JH
J Clin Endocrinol Metab; 1974 Apr; 38(4):706-9. PubMed ID: 4820669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
